THE NOOHRA LIMITEDActive

Company number 11334263Private limited companyIncorporated 2018

Key figures

£29,253+43.7%
Net assets 2025
+81.0%
Average annual growth 2019/20–2025
010 k20 k30 k2019/2020212022202320242025

Like most small UK companies, THE NOOHRA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k2019/2020212022202320242025
Filed accounts2019/20–2025
20212022202320242025
Cash at bank and in hand8,5207499032,5721,900
Total assets20,01823,3696,79310,4129,851
Total liabilities4,6736,71615,54313,6515,083
Net assets / total equity19,79619,90018,34720,36129,253
Average number of employees12333

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: THE NOOHRA LIMITED

Company

THE NOOHRA LIMITED is a private limited company registered with Companies House under company number 11334263. It was incorporated on 27 Apr 2018. Its status is active. The registered office is in Rochester (ME2). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200), wholesale of pharmaceutical goods (46460), general medical practice activities (86210), activities of professional membership organizations (94120).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £29,253, up 43.7% on the previous year. Cash at bank and in hand was £1,900. Total assets were £9,851 and total liabilities £5,083. The company had an average of 3 employees. Figures are available for 6 financial years (2019/20–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 10 May 2027.